Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Oncology Letters|August 7, 2012
Fluorine-18-labeled boronophenylalanine positron emission tomography for oral cancers: Qualitative and quantitative analyses of malignant tumors and normal structures in oral and maxillofacial regionsYasunori Ariyoshi, Masashi Shimahara, Yoshihiro Kimura, et al.International Journal of Clinical Oncology|June 17, 2008
Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002Yasunori Ariyoshi, Masashi Shimahara, Ken Omura, et al.Oncology Reports|September 6, 2007
Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasisYasunori Ariyoshi, Shin-Ichi Miyatake, Yoshihiro Kimura, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2011
Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarrayJunichi Matsubara, Kazufumi Honda, Masaya Ono, et al.Plos One|October 12, 2012
Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validationKazufumi Honda, Takuji Okusaka, Klaus Felix, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2010
Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancerJunichi Matsubara, Kazufumi Honda, Masaya Ono, et al.Cancer Science|January 5, 2011
Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarrayYusuke Murakoshi, Kazufumi Honda, Shizuka Sasazuki, et al.Scientific Reports|November 10, 2015
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoformsKazufumi Honda, Michimoto Kobayashi, Takuji Okusaka, et al.Plos One|September 1, 2016
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based ProteomicsToshihiro Yoneyama, Sumio Ohtsuki, Kazufumi Honda, et al.The Journal of Biological Chemistry|August 22, 2009
Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomicsMasaya Ono, Junichi Matsubara, Kazufumi Honda, et al.Pageof 3